OraSure Technologies, Inc. (OSUR)
Largest Insider Buys in Sector
OSUR Stock Price History Chart
OSUR Stock Performance
About OraSure Technologies, Inc.
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick …
Insider Activity of OraSure Technologies, Inc.
Over the last 12 months, insiders at OraSure Technologies, Inc. have bought $0 and sold $194,219 worth of OraSure Technologies, Inc. stock.
On average, over the past 5 years, insiders at OraSure Technologies, Inc. have bought $390,761 and sold $107,749 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $492,810 was made by McGrath Kenneth J (Chief Financial Officer) on 2023‑05‑30.
List of Insider Buy and Sell Transactions, OraSure Technologies, Inc.
| 2023-12-19 | Sale | Chief Product Officer | 24,129 0.0327% | $8.05 | $194,219 | -36.14% | ||
| 2023-08-15 | Sale | SVP Finance & CAO | 1,758 0.0024% | $6.50 | $11,427 | -7.68% | ||
| 2023-05-30 | Chief Financial Officer | 100,000 0.1373% | $4.93 | $492,810 | +22.40% | |||
| 2022-08-26 | 50,000 0.0689% | $4.00 | $200,000 | +28.00% | ||||
| 2022-08-25 | 6,000 0.0083% | $4.19 | $25,138 | +22.20% | ||||
| 2022-08-17 | 2,200 0.0031% | $4.39 | $9,658 | +17.91% | ||||
| 2022-08-12 | 12,000 0.0163% | $4.49 | $53,916 | +10.96% | ||||
| 2020-12-23 | Sale | EVP & BU Lead - Molecular | 10,000 0.0141% | $11.76 | $117,600 | -9.40% | ||
| 2019-05-14 | President and CEO | 2,000 0.0032% | $8.56 | $17,120 | -7.44% | |||
| 2019-05-13 | SVP & General Counsel | 20,000 0.0325% | $8.55 | $170,974 | -5.05% | |||
| 2019-05-10 | CFO | 20,000 0.032% | $9.03 | $180,627 | -11.69% | |||
| 2019-04-01 | Sale | President and CEO | 33,334 0.0474% | $9.71 | $323,768 | -26.92% | ||
| 2018-08-27 | Sale | director | 16,000 0.0262% | $16.29 | $260,640 | -31.51% | ||
| 2018-02-16 | Sale | EVP & BU Lead - Molecular | 20,000 0.0215% | $11.98 | $239,600 | -12.28% | ||
| 2018-02-15 | Sale | director | 46,666 0.056% | $13.15 | $613,495 | -10.94% | ||
| 2018-02-15 | Sale | EVP & BU Lead - Molecular | 20,000 0.0218% | $11.95 | $239,040 | -10.94% | ||
| 2017-11-07 | director | 5,000 0.0085% | $14.23 | $71,164 | +21.88% | |||
| 2017-10-04 | Sale | President & CEO | 45,846 0.0763% | $23.00 | $1.05M | -24.60% | ||
| 2017-09-29 | Sale | President & CEO | 50,000 0.0834% | $22.55 | $1.13M | -23.29% | ||
| 2017-08-31 | Sale | See Remarks | 18,224 0.0222% | $14.95 | $272,412 | -14.60% |
Insider Historical Profitability
| McGrath Kenneth J | Chief Financial Officer | 285512 0.3828% | $3.86 | 1 | 0 | +22.4% |
| TANG STEPHEN S PHD | President and CEO | 119960 0.1608% | $3.86 | 1 | 6 | <0.0001% |
| Celano Michael | 111823 0.1499% | $3.86 | 2 | 4 | <0.0001% | |
| SPAIR RONALD H | COO & CFO | 109066 0.1462% | $3.86 | 1 | 18 | <0.0001% |
| LANCASTER RONNY B | 104782 0.1405% | $3.86 | 5 | 5 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $77.5M | 17.04 | 12.6M | -0.16% | -$125,712.15 | <0.01 | |
| The Vanguard Group | $33.27M | 7.31 | 5.41M | +1.88% | +$612,367.80 | <0.01 | |
| Dimensional Fund Advisors | $27.8M | 6.11 | 4.52M | +15.72% | +$3.78M | 0.01 | |
| Camber Capital Management Lp | $26.14M | 5.75 | 4.25M | 0% | +$0 | 0.92 | |
| Neuberger Berman | $24.96M | 5.49 | 4.06M | +29.73% | +$5.72M | 0.02 |